{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:40:08Z","timestamp":1746060008901,"version":"3.40.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,30]]},"DOI":"10.7759\/cureus.83268","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:51Z","timestamp":1746057651000},"source":"Crossref","is-referenced-by-count":0,"title":["Stroke and Thrombotic Events Associated With Concomitant Use of Oral Anticoagulants and Antiepileptic Drugs in the United States and Japan"],"prefix":"10.7759","author":[{"given":"Tomiko","family":"Sunaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons","volume":"140","author":"January CT","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al.. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019, 140:125-51. 10.1161\/CIR.0000000000000665","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel TL","year":"2020","unstructured":"Ortel TL, Neumann I, Ageno W, et al.. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020, 4:4693-738. 10.1182\/bloodadvances.2020001830","journal-title":"Blood Adv"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009616","article-title":"Prevalence of individuals experiencing the effects of stroke in Canada: trends and projections","volume":"46","author":"Krueger H","year":"2015","unstructured":"Krueger H, Koot J, Hall RE, O'Callaghan C, Bayley M, Corbett D. Prevalence of individuals experiencing the effects of stroke in Canada: trends and projections. Stroke. 2015, 46:2226-31. 10.1161\/STROKEAHA.115.009616","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2025.108846","article-title":"Incidence and influencing factors of post-stroke seizure after endovascular treatment of ischemic stroke - a systematic review and meta-analysis","volume":"252","author":"Isah FM","year":"2025","unstructured":"Isah FM, Wang S, Djatche WH, Song M, Li CX. Incidence and influencing factors of post-stroke seizure after endovascular treatment of ischemic stroke - a systematic review and meta-analysis. Clin Neurol Neurosurg. 2025, 252:10.1016\/j.clineuro.2025.108846","journal-title":"Clin Neurol Neurosurg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/clc.70115","article-title":"National trends in mortality due to ischemic stroke among older adults with atrial fibrillation in the USA, 1999-2020","volume":"48","author":"Khan SA","year":"2025","unstructured":"Khan SA, Assad AA, Ashraf H, et al.. National trends in mortality due to ischemic stroke among older adults with atrial fibrillation in the USA, 1999-2020. Clin Cardiol. 2025, 48:10.1002\/clc.70115","journal-title":"Clin Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/epi.18396","article-title":"Differences in patterns of outpatient epilepsy-specific medication initiation after acute ischemic stroke in the Medicare population","author":"Donahue MA","year":"2025","unstructured":"Donahue MA, Brooks JD, Hsu J, et al.. Differences in patterns of outpatient epilepsy-specific medication initiation after acute ischemic stroke in the Medicare population. Epilepsia. 2025, 10.1111\/epi.18396","journal-title":"Epilepsia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061120","article-title":"Drug-drug interactions of direct oral anticoagulants (DOACs): from pharmacological to clinical practice","volume":"14","author":"Ferri N","year":"2022","unstructured":"Ferri N, Colombo E, Tenconi M, Baldessin L, Corsini A. Drug-drug interactions of direct oral anticoagulants (DOACs): from pharmacological to clinical practice. Pharmaceutics. 2022, 14:10.3390\/pharmaceutics14061120","journal-title":"Pharmaceutics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100137","article-title":"Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: a systematic review","volume":"7","author":"Candeloro M","year":"2023","unstructured":"Candeloro M, Carlin S, Shapiro MJ, Douketis JD. Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: a systematic review. Res Pract Thromb Haemost. 2023, 7:10.1016\/j.rpth.2023.100137","journal-title":"Res Pract Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/17151635221116100","article-title":"DOAC drug interactions management resource","volume":"155","author":"Chadha A","year":"2022","unstructured":"Chadha A, Guirguis M, Bungard TJ. DOAC drug interactions management resource. Can Pharm J (Ott). 2022, 155:315-25. 10.1177\/17151635221116100","journal-title":"Can Pharm J (Ott)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvz035","article-title":"Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs","volume":"6","author":"Wang CL","year":"2020","unstructured":"Wang CL, Wu VC, Chang KH, et al.. Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs. Eur Heart J Cardiovasc Pharmacother. 2020, 6:147-54. 10.1093\/ehjcvp\/pvz035","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref11","unstructured":"FDA Adverse Event Reporting System (FAERS) Public Dashboard. (2025). https.\/\/www.fda.gov\/drugs\/fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-public-d...."},{"key":"ref12","unstructured":"Drug adverse reaction database terms of use. (2025). https.\/\/www.pmda.go.jp\/safety\/info-services\/drugs\/adr-info\/suspected-adr\/0003.html."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5772\/50095","article-title":"Data mining techniques in pharmacovigilance: analysis of the publicly accessible FDA Adverse Event Reporting System (AERS)","author":"Poluzzi E","year":"2012","unstructured":"Poluzzi E, Raschi E, Piccinni C, De Ponti F. Data mining techniques in pharmacovigilance: analysis of the publicly accessible FDA Adverse Event Reporting System (AERS). Data Mining Applications in Engineering and Medicine. Karahoca A (ed): IntechOpen, London, UK; 2012. 225-43. 10.5772\/50095"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-023-01052-1","article-title":"Levetiracetam interaction with direct oral anticoagulants: a pharmacovigilance study","volume":"37","author":"Kaoud MA","year":"2023","unstructured":"Kaoud MA, Nissan R, Segev A, Sabbag A, Orion D, Maor E. Levetiracetam interaction with direct oral anticoagulants: a pharmacovigilance study. CNS Drugs. 2023, 37:1111-21. 10.1007\/s40263-023-01052-1","journal-title":"CNS Drugs"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33876-8","article-title":"The efficacy of direct oral anticoagulants in patients on concomitant treatment with levetiracetam","volume":"13","author":"Mavri A","year":"2023","unstructured":"Mavri A, Ilc S. The efficacy of direct oral anticoagulants in patients on concomitant treatment with levetiracetam. Sci Rep. 2023, 13:10.1038\/s41598-023-33876-8","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2024.06.002","article-title":"Direct oral anticoagulants and concomitant anti-seizure medications: a retrospective, case-control study in a real-world setting","volume":"46","author":"Rota E","year":"2024","unstructured":"Rota E, Immovilli P, Pappalardo I, et al.. Direct oral anticoagulants and concomitant anti-seizure medications: a retrospective, case-control study in a real-world setting. Clin Ther. 2024, 46:26-30. 10.1016\/j.clinthera.2024.06.002","journal-title":"Clin Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fdsfr.2023.1323057","article-title":"Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems","volume":"3","author":"Cutroneo PM","year":"2024","unstructured":"Cutroneo PM, Sartori D, Tuccori M, et al.. Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems. Front Drug Saf Regul. 2024, 3:10.3389\/fdsfr.2023.1323057","journal-title":"Front Drug Saf Regul"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0162-y","article-title":"Adverse drug reaction reporting by patients: an overview of fifty countries","volume":"37","author":"Margraff F","year":"2014","unstructured":"Margraff F, Bertram D. Adverse drug reaction reporting by patients: an overview of fifty countries. Drug Saf. 2014, 37:409-19. 10.1007\/s40264-014-0162-y","journal-title":"Drug Saf"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2022.10.001","article-title":"Women and ischemic stroke: disparities and outcomes","volume":"41","author":"Cherian L","year":"2023","unstructured":"Cherian L. Women and ischemic stroke: disparities and outcomes. Neurol Clin. 2023, 41:265-81. 10.1016\/j.ncl.2022.10.001","journal-title":"Neurol Clin"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2024.101908","article-title":"Racial, biological sex, and geographic disparities of venous thromboembolism in the United States, 2016 to 2019","volume":"12","author":"Afifi AM","year":"2024","unstructured":"Afifi AM, Leverich M, Tadrousse K, Ren G, Nazzal M. Racial, biological sex, and geographic disparities of venous thromboembolism in the United States, 2016 to 2019. J Vasc Surg Venous Lymphat Disord. 2024, 12:10.1016\/j.jvsv.2024.101908","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2369","article-title":"Association between use of pharmacokinetic-interacting drugs and effectiveness and safety of direct acting oral anticoagulants: nested case-control study","volume":"110","author":"Gronich N","year":"2021","unstructured":"Gronich N, Stein N, Muszkat M. Association between use of pharmacokinetic-interacting drugs and effectiveness and safety of direct acting oral anticoagulants: nested case-control study. Clin Pharmacol Ther. 2021, 110:1526-36. 10.1002\/cpt.2369","journal-title":"Clin Pharmacol Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0342-7","article-title":"Pharmacokinetics and pharmacodynamics of edoxaban, a non-vitamin\u00a0K antagonist oral anticoagulant that inhibits clotting factor\u00a0Xa","volume":"55","author":"Parasrampuria DA","year":"2016","unstructured":"Parasrampuria DA, Truitt KE. Pharmacokinetics and pharmacodynamics of edoxaban, a non-vitamin\u00a0K antagonist oral anticoagulant that inhibits clotting factor\u00a0Xa. Clin Pharmacokinet. 2016, 55:641-55. 10.1007\/s40262-015-0342-7","journal-title":"Clin Pharmacokinet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-019-01866-1","article-title":"Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy","volume":"48","author":"Di Gennaro L","year":"2019","unstructured":"Di Gennaro L, Lancellotti S, De Cristofaro R, De Candia E. Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy. J Thromb Thrombolysis. 2019, 48:528-31. 10.1007\/s11239-019-01866-1","journal-title":"J Thromb Thrombolysis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel J","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, et al.. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018, 39:1330-93. 10.1093\/eurheartj\/ehy136","journal-title":"Eur Heart J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2024.2057","article-title":"Direct-acting oral anticoagulants and antiseizure medications for atrial fibrillation and epilepsy and risk of thromboembolic events","volume":"81","author":"Acton EK","year":"2024","unstructured":"Acton EK, Hennessy S, Gelfand MA, et al.. Direct-acting oral anticoagulants and antiseizure medications for atrial fibrillation and epilepsy and risk of thromboembolic events. JAMA Neurol. 2024, 81:835-44. 10.1001\/jamaneurol.2024.2057","journal-title":"JAMA Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013267","article-title":"Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: systematic review and meta-analysis","volume":"132","author":"Sharma M","year":"2015","unstructured":"Sharma M, Cornelius VR, Patel JP, Davies JG, Molokhia M. Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: systematic review and meta-analysis. Circulation. 2015, 132:194-204. 10.1161\/CIRCULATIONAHA.114.013267","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(91)90585-w","article-title":"Canadian Atrial Fibrillation Anticoaguiation (CAFA) study","volume":"18","author":"Connolly SJ","year":"1991","unstructured":"Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoaguiation (CAFA) study. J Am Coll Cardiol. 1991, 18:349-55. 10.1016\/0735-1097(91)90585-w","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14121125","article-title":"Long-term safety and efficacy of lacosamide combined with NOACs in post-stroke epilepsy and atrial fibrillation: a prospective longitudinal study","volume":"14","author":"Mangiardi M","year":"2024","unstructured":"Mangiardi M, Pezzella FR, Cruciani A, Alessiani M, Anticoli S. Long-term safety and efficacy of lacosamide combined with NOACs in post-stroke epilepsy and atrial fibrillation: a prospective longitudinal study. J Pers Med. 2024, 14:10.3390\/jpm14121125","journal-title":"J Pers Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12809","article-title":"Shift from older- to newer-generation antiseizure medications in people with acute ischemic stroke in Australia: a population-based study","volume":"8","author":"Kim SJ","year":"2023","unstructured":"Kim SJ, Wood S, Marquina C, Foster E, Bell JS, Ilom\u00e4ki J. Shift from older- to newer-generation antiseizure medications in people with acute ischemic stroke in Australia: a population-based study. Epilepsia Open. 2023, 8:1413-24. 10.1002\/epi4.12809","journal-title":"Epilepsia Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/332530-stroke-and-thrombotic-events-associated-with-concomitant-use-of-oral-anticoagulants-and-antiepileptic-drugs-in-the-united-states-and-japan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:52Z","timestamp":1746057652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/332530-stroke-and-thrombotic-events-associated-with-concomitant-use-of-oral-anticoagulants-and-antiepileptic-drugs-in-the-united-states-and-japan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.83268","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,30]]}}}